Co-Founder, CEO & Chairman
Gilad Savion boasts a highly successful track record as an entrepreneur. His expertise includes founding new companies, raising capital, market penetration and managing best talents for over 15 years. Currently the CEO of LAVIOR, earlier in his career, Gilad was Founder & CEO of Savion Yezum Ubnia (acquired by B-Yair), CEO & Founder of NOGACOM (acquired by Sardi Group); VP Sales, Onigma (acquired by McAfee); Director of EMEA Sales, Port Authority Technologies (acquired by WebSense) and Security Product Manager, IBM.
He holds an MBA in Communications from Clark University, BA, Marketing & Business Development, Israel College of Management and is a Certified Practical Engineer, Industrial Engineering, Ariel College, Israel.
Co-Founder, EVP Marketing
Anabelle Savion is a seasoned international marketing and communications professional with experience business development, branding and marketing, having lived and worked in Paris, London, Madrid, Sydney, New York and Tel Aviv. Fluent in four languages.
She holds an MBA from ESCP Europe (European School of Management), Paris/London/New York and an MA in International Communications, Macquarie University, Sydney.
Chief Information Officer
Paul Hinds served as Managing Director within PwC’s Cybersecurity, Privacy, and Risk Management practice for over 20 years, assisting organizations solve a wide range of technical security and privacy compliance requirements. His experience includes addressing business strategy, operations and IT across a wide range of industries including healthcare, high tech, finance, and global manufacturing. Paul serves as technical security and privacy advisor from billion-dollar companies to innovative technology and product start-ups. He is a frequent speaker and author.
GIL ATZMON, PhD
Chief R&D Officer
Professor Gil Atzmon is an Associate Professor in both University of Haifa, Israel and Albert Einstein College of Medicine, New York, USA. His research focuses on the challenging field of epigenetics and genetics in diseases, aging and longevity. The foremost focus of his research career has been the understanding of the association of the total genome, to diseases, health, performance and longevity. He has international collaborations with scientists and researchers across the world and has more than 120 scientific publications in leading scientific journals.